DCGI approves market authorization for Covovax, SII’s Covid vaccine, as a booster dose

  • DCGI approves market authorization for Covovax, SII’s Covid vaccine, as a booster dose.
  • Recommendation was given by the Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO).

Via

Sign Up for nextbigwhat newsletter

The smartest newsletter, partly written by AI.

Download Pluggd.in, the short news app for busy professionals